We next examined the expression of FOXL2 in the metastatic foci of the primary ovarian cancers in the lung, brain, lymph node and peritoneum, including omentum, mesentery and uterine surface, and the primary lesions of the secondary ovarian tumors of colon, rectum, stomach and pancreas origin. Here, FOXL2 is linked to ovarian carcinoma.